Particularly, a prevalence of SERCA2b over SERCA3 has been reported in non-differentiated vs. differentiated AML [49], colon carcinoma [50] and gastric carcinoma [51] cells. The gene discussed is ATP2A3; the disease is acute myeloid leukemia.